Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Derosa

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2011
Pioglitazone is a valid alternative to rosiglitazoneGiuseppe Derosa
Drugs|October 2, 2010
Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agentsGiuseppe Derosa
Vascular Health and Risk Management|December 15, 2007
Optimizing combination treatment in the management of type 2 diabetesGiuseppe Derosa, Salvadeo Sibilla
Vascular Health and Risk Management|November 24, 2016
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitusGiuseppe Derosa, Pamela Maffioli
Expert Review of Cardiovascular Therapy|June 10, 2010
Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patientsGiuseppe Derosa, Pamela Maffioli
Expert Opinion on Drug Safety|May 20, 2011
Drug safety evaluation of amlodipineGiuseppe Derosa, Pamela Maffioli
Diabetes Technology & Therapeutics|May 18, 2010
Effects of thiazolidinediones and sulfonylureas in patients with diabetesGiuseppe Derosa, Pamela Maffioli
Diabetes Technology & Therapeutics|February 14, 2012
Dipeptidyl peptidase-4 inhibitors: 3 years of experienceGiuseppe Derosa, Pamela Maffioli
Current Clinical Pharmacology|March 22, 2012
GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacyGiuseppe Derosa, Pamela Maffioli
Expert Opinion on Drug Safety|March 24, 2012
Anti-obesity drugs: a review about their effects and their safetyGiuseppe Derosa, Pamela Maffioli
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2011
Pioglitazone is a valid alternative to rosiglitazoneGiuseppe Derosa
Drugs|October 2, 2010
Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agentsGiuseppe Derosa
Vascular Health and Risk Management|December 15, 2007
Optimizing combination treatment in the management of type 2 diabetesGiuseppe Derosa, Salvadeo Sibilla
Vascular Health and Risk Management|November 24, 2016
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitusGiuseppe Derosa, Pamela Maffioli
Expert Review of Cardiovascular Therapy|June 10, 2010
Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patientsGiuseppe Derosa, Pamela Maffioli
Expert Opinion on Drug Safety|May 20, 2011
Drug safety evaluation of amlodipineGiuseppe Derosa, Pamela Maffioli
Diabetes Technology & Therapeutics|May 18, 2010
Effects of thiazolidinediones and sulfonylureas in patients with diabetesGiuseppe Derosa, Pamela Maffioli
Diabetes Technology & Therapeutics|February 14, 2012
Dipeptidyl peptidase-4 inhibitors: 3 years of experienceGiuseppe Derosa, Pamela Maffioli
Current Clinical Pharmacology|March 22, 2012
GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacyGiuseppe Derosa, Pamela Maffioli
Expert Opinion on Drug Safety|March 24, 2012
Anti-obesity drugs: a review about their effects and their safetyGiuseppe Derosa, Pamela Maffioli
Pageof 25